Contents

Black was born on 14 June 1924 in Uddingston, Lanarkshire, the fourth of five sons of a Baptist family which traced its origins to Balquhidder, Perthshire.[6] His father was a mining engineer.[6] He was brought up in Fife, educated at Beath High School, Cowdenbeath, and, at the age of 15, won a scholarship to the University of St Andrews.[6] His family had been too poor to send him to university and he had been persuaded to sit the St Andrews entrance exam by his maths teacher at Beath.[7]

After graduating, he stayed at University College to join the physiology department as an assistant lecturer before taking a lecturer position at the University of Malaya.[8][9] Black had decided against a career as a medical practitioner as he objected to what he considered the insensitive treatment of patients at the time.[9]

Black had large debts upon his graduation from university, so he took a teaching job in Singapore for three years, before moving to London in 1950[10] and then on to join the University of Glasgow (Veterinary School) where he established the Physiology Department and developed an interest in the way adrenaline affects the human heart, particularly in those suffering from angina.[11] Having formulated a theory of an approach by which the effects of adrenaline might be annulled, he joined ICI Pharmaceuticals in 1958, remaining with the company until 1964, during which time he developed propranolol,[3] which later became the world's best-selling drug.[11] During this time Black pioneered a method of research whereby drug molecules were purposefully built instead of being synthesised first and then investigated for their potential medical uses.[9] The discovery of propranolol was hailed as the greatest breakthrough in the treatment of heart disease since the discovery of digitalis.[11]

At the same time, Black was developing a similar method of treatment for stomach ulcers, but ICI did not wish to pursue the idea so Black resigned in 1964 and joined Smith, Kline and French where he worked for nine years until 1973.[12] While there, Black developed his second major drug, cimetidine, which was launched under the brand name Tagamet in 1975 and soon outsold propranolol to become the world's largest-selling prescription drug.[11]

Black was appointed professor, and head of department, of pharmacology at University College London in 1973 where he established a new undergraduate course in medicinal chemistry[6] but he became frustrated by the lack of funding for research and accepted the post of director of therapeutic research at the Wellcome Research Laboratories in 1978.[9] However he did not agree with his immediate boss there, Sir John Vane, and resigned in 1984.[9] Black then became Professor of Analytical Pharmacology at the Rayne Institute of King's College London medical school, where he remained until 1992.[9] He established the James Black Foundation in 1988 with funding from Johnson and Johnson and led a team of 25 scientists in drugs research, including work on gastrin inhibitors which can prevent some stomach cancers.[9]

Black contributed to basic scientific and clinical knowledge in cardiology, both as a physician and as a basic scientist. His invention of propranolol, the beta adrenergic receptor antagonist that revolutionised the medical management of angina pectoris, is considered to be one of the most important contributions to clinical medicine and pharmacology of the 20th century.[13][14] Propranolol has been described as the greatest breakthrough in heart disease treatments since the 18th century discovery of digitalis and has benefited millions of people.[9] Black's method of research, his discoveries about adrenergic pharmacology, and his clarification of the mechanisms of cardiac action are all strengths of his work.[15]

In 1980, Black's association with the University of Dundee was renewed when the institution recognised his many achievements by conferring him with the Honorary Degree of Doctor of Laws. In 1992 he accepted an offer to succeed the 16th Earl of Dalhousie as Chancellor of the University and was installed as Chancellor at the award ceremony held in Dundee Repertory Theatre on 29 April 1992. Appropriately the first degree he conferred was to Professor Robert Campbell Garry, who had been responsible for his original appointment at University College Dundee. Sir James remarked at this ceremony that by returning to Dundee he was "in a real sense, coming home".[8]

As Chancellor, Sir James Black did much to promote the University of Dundee and was a popular figure within the University. He was awarded a second honorary degree, that of Doctor of Science, in 2005. He retired from his post the following year, and his association with the University of Dundee was marked with launching of the £20 million Sir James Black Centre. The centre, intended to promote interdisciplinary research in the life sciences, was opened by Sydney Brenner in 2006. Sir James Black himself visited the centre in October 2006 and was reportedly excited and pleased by what he saw.[8]

Has made outstanding contributions, based on fundamental considerations of receptor theory, to the development of new drugs of clinical importance. Introduced the first effective beta blockers and analysed their cardiovascular effects. These drugs have opened up new perspectives for the treatment of angina pectoris, cardiac irregularities and hypertension. More recently, in a concerted drive carried out with great vision, he has developed a new type of histamine antagonist capable of inhibiting gastric acid secretion induced by histamine or pentagastrin. Apart from its practical implications this work has considerable fundamental importance since it provided evidence for the existence of a new type of histamine receptor. This work has also provided experimental support for the hypothesis that endogenous histamine may be involved in the secretion of acid in the stomach.[1]

Black met Hilary Joan Vaughan (1924–1986) at a ball at university in 1944 and the couple married in 1946 upon his graduation. He described her as the "mainspring" of his life until she died aged 61 in Surrey.[6][21] The couple had a daughter, Stephanie, born in 1951.[6] Black remarried in 1994, to Professor Rona MacKie.[9] Black was a very private man who was averse to publicity and was horrified to discover he had won the Nobel Prize.[9]

Black died, aged 85, on the morning of 22 March 2010 after a long illness. His death was announced by the University of Dundee, where Black served as Chancellor from 1992 to 2006.[22] His funeral was held on 29 March at St. Columba's Church, London.[10] He is buried at the Ardclach cemetery, a parish established in 1655, near Nairn, Scotland. Upon hearing of Black's death, Professor Pete Downes, Principal and Vice-Chancellor of the University of Dundee said Black "was a great scientist, but he was also a great man to know" while the BBC said he was "hailed as one of the great Scottish scientists of the 20th Century".[18] He was described by The Daily Telegraph as the man who earned the most for the pharmaceutical industry through his drug development, though he received little personal financial gain from his work.[9]

In 2010 the Bute Medical School of the University of St Andrews, where Black had studied his initial degree in medicine, announced that an honorary 'Sir James Black Chair of Medicine' would be created. In September 2010 the first Chair of Medicine at the University was given to Professor Stephen H Gillespie MD, DSc, FRCP (Edin), FRC Path, who left his post as Professor of Medical Microbiology at UCL.